OPINION | With proper patent protection, vaccines offer plenty of promise

Posted 4/14/21

Since the start of the pandemic, leading drug makers such as Pfizer, Moderna, AstraZeneca, and Johnson & Johnson have relied on robust intellectual property (IP) protections in developing …

This item is available in full to subscribers.